Recognizing the contribution of UGT2B10 genotype to serum (or saliva) cotinine levels is critical to understanding the relationship of an individual's cotinine level to smoking exposures and ultimately the relationship to lung cancer risk. Here, UGT2B10 is linked to lung carcinoma.